Literature DB >> 33323539

Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition.

Xiaofeng Yuan1, Lianhua Piao2, Luhui Wang1, Xu Han3, Lei Tong1, Shijie Shao1, Xiaoshuang Xu2, Ming Zhuang1, Zhiwei Liu1.   

Abstract

Erythrocyte membrane protein band 4.1-like 3 (EPB41L3) is an important membrane skeletal protein that may interact with numerous membrane proteins. Loss of EPB41L3 is reported in multiple cancer types, and it is originally identified as a tumor suppressor. In this study, through analyzing expression profiling retrieved from the Gene Expression Omnibus (GEO) dataset, we find that EPB41L3 is upregulated in primary osteosarcoma (OS) and osteosarcoma cell lines. Importantly, EPB41L3 may promote osteosarcoma cell proliferation and suppress osteosarcoma cell migration and invasion. Reduced EPB41L3 leads to a decrease of E-cadherin as well as an increase of N-cadherin and Vimentin, implying a prominent epithelial-to-mesenchymal transition. Furthermore, we demonstrate that EPB41L3 inhibits the epithelial-to-mesenchymal transition through destabilizing the Snai1 protein, one of the most important transcription factors of the epithelial-to-mesenchymal transition process. Collectively, our study has first established the complex and vital roles of EPB41L3 and implicated EPB41L3 as a potential biomarker in osteosarcoma.

Entities:  

Keywords:  4.1B; EMT; EPB41L3; Snai1; osteosarcoma

Year:  2020        PMID: 33323539     DOI: 10.18632/aging.202158

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  1 in total

1.  Induced resistance to ifosfamide in osteosarcoma cells suggests a more aggressive tumor profile.

Authors:  Maria Tereza de Oliveira Rodrigues; Lucas Pereira da Silva; Robert Edward Pogue; Juliana Lott de Carvalho; Andrea Barretto Motoyama; Thuany de Alencar E Silva; Hilana Dos Santos Sena Brunel; Maria Fátima Grossi de Sá; Rosângela Vieira de Andrade
Journal:  Biochem Biophys Rep       Date:  2022-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.